nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—Vandetanib—KDR—age related macular degeneration	0.0218	0.541	CrCbGaD
Gefitinib—Vandetanib—VEGFA—age related macular degeneration	0.0185	0.459	CrCbGaD
Gefitinib—SBK1—eye—age related macular degeneration	0.00906	0.178	CbGeAlD
Gefitinib—SBK1—retina—age related macular degeneration	0.00898	0.176	CbGeAlD
Gefitinib—CSNK1E—retina—age related macular degeneration	0.00496	0.0971	CbGeAlD
Gefitinib—ERBB3—connective tissue—age related macular degeneration	0.00465	0.0911	CbGeAlD
Gefitinib—MKNK2—eye—age related macular degeneration	0.00459	0.0899	CbGeAlD
Gefitinib—MKNK2—retina—age related macular degeneration	0.00455	0.0891	CbGeAlD
Gefitinib—MKNK1—eye—age related macular degeneration	0.00453	0.0888	CbGeAlD
Gefitinib—MKNK1—retina—age related macular degeneration	0.00449	0.088	CbGeAlD
Gefitinib—MKNK2—connective tissue—age related macular degeneration	0.00442	0.0867	CbGeAlD
Gefitinib—IRAK1—Immune System—C2—age related macular degeneration	0.00111	0.00123	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—SQSTM1—age related macular degeneration	0.00111	0.00123	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RHO—age related macular degeneration	0.00111	0.00122	CbGpPWpGaD
Gefitinib—EGFR—Disease—NMNAT1—age related macular degeneration	0.00109	0.0012	CbGpPWpGaD
Gefitinib—EGFR—Disease—RDH8—age related macular degeneration	0.00109	0.0012	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CFB—age related macular degeneration	0.00109	0.00119	CbGpPWpGaD
Gefitinib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00107	0.00118	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CFH—age related macular degeneration	0.00107	0.00118	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CFB—age related macular degeneration	0.00104	0.00114	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00104	0.00114	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C9—age related macular degeneration	0.00104	0.00114	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00103	0.00113	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—CD36—age related macular degeneration	0.00101	0.00111	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ABCA4—age related macular degeneration	0.00101	0.00111	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RPE65—age related macular degeneration	0.001	0.0011	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.000999	0.0011	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.000995	0.0011	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.000992	0.00109	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CST3—age related macular degeneration	0.000989	0.00109	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—RAD51B—age related macular degeneration	0.000987	0.00109	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ABCA4—age related macular degeneration	0.00097	0.00107	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000969	0.00107	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—CD36—age related macular degeneration	0.000959	0.00106	CbGpPWpGaD
Gefitinib—EGFR—Disease—RPE65—age related macular degeneration	0.000957	0.00105	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000954	0.00105	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CFH—age related macular degeneration	0.000932	0.00103	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000931	0.00102	CbGpPWpGaD
Gefitinib—MAP2K5—Focal Adhesion—VEGFA—age related macular degeneration	0.000919	0.00101	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.000918	0.00101	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—C3—age related macular degeneration	0.000909	0.001	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CFB—age related macular degeneration	0.000903	0.000994	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—VEGFA—age related macular degeneration	0.000899	0.000989	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CFI—age related macular degeneration	0.000899	0.000989	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—KDR—age related macular degeneration	0.000895	0.000985	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000891	0.000981	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFBR1—age related macular degeneration	0.000888	0.000977	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RHO—age related macular degeneration	0.000876	0.000964	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—CRP—age related macular degeneration	0.000865	0.000952	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000856	0.000942	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.000856	0.000942	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000849	0.000934	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RHO—age related macular degeneration	0.000844	0.000929	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CFHR3—age related macular degeneration	0.000835	0.000919	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—SQSTM1—age related macular degeneration	0.000833	0.000917	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—TLR4—age related macular degeneration	0.000829	0.000912	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.000819	0.000901	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ABCA4—age related macular degeneration	0.000808	0.000889	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.0008	0.00088	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—RHO—age related macular degeneration	0.000796	0.000875	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000795	0.000874	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000795	0.000874	CbGpPWpGaD
Gefitinib—ABCB1—retina—age related macular degeneration	0.000792	0.0155	CbGeAlD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000781	0.00086	CbGpPWpGaD
Gefitinib—EGFR—Disease—ABCA4—age related macular degeneration	0.000771	0.000849	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RDH8—age related macular degeneration	0.000767	0.000844	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CD36—age related macular degeneration	0.000765	0.000842	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CST3—age related macular degeneration	0.000754	0.000829	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.000748	0.000823	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C2—age related macular degeneration	0.000745	0.000819	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD36—age related macular degeneration	0.000734	0.000808	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000725	0.000798	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—C3—age related macular degeneration	0.000725	0.000798	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RHO—age related macular degeneration	0.000703	0.000773	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000696	0.000766	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000696	0.000766	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—C3—age related macular degeneration	0.000696	0.000766	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CRP—age related macular degeneration	0.000689	0.000759	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.000683	0.000752	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFBR1—age related macular degeneration	0.000677	0.000745	CbGpPWpGaD
Gefitinib—EGFR—Disease—RHO—age related macular degeneration	0.000671	0.000738	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RPE65—age related macular degeneration	0.00067	0.000737	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—SQSTM1—age related macular degeneration	0.000664	0.000731	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—TLR4—age related macular degeneration	0.000661	0.000727	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—VEGFA—age related macular degeneration	0.000642	0.000706	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CD36—age related macular degeneration	0.000637	0.000701	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000636	0.0007	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CFH—age related macular degeneration	0.000623	0.000686	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFBR1—age related macular degeneration	0.000622	0.000684	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000613	0.000675	CbGpPWpGaD
Gefitinib—MKNK1—Disease—APOE—age related macular degeneration	0.000612	0.000674	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CFB—age related macular degeneration	0.000604	0.000665	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—C3—age related macular degeneration	0.000603	0.000664	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.000603	0.000664	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000593	0.000652	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—KDR—age related macular degeneration	0.000584	0.000643	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00058	0.000638	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.000579	0.000638	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CRP—age related macular degeneration	0.000574	0.000632	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000567	0.000624	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SQSTM1—age related macular degeneration	0.000564	0.00062	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD36—age related macular degeneration	0.000559	0.000615	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—SQSTM1—age related macular degeneration	0.000553	0.000609	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—TLR4—age related macular degeneration	0.00055	0.000606	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.000541	0.000595	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ABCA4—age related macular degeneration	0.00054	0.000594	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000536	0.00059	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—C3—age related macular degeneration	0.000529	0.000583	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000529	0.000582	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000528	0.000581	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000506	0.000557	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CRP—age related macular degeneration	0.000504	0.000554	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000502	0.000553	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—VEGFA—age related macular degeneration	0.000493	0.000543	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000492	0.000541	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000491	0.00054	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—TLR4—age related macular degeneration	0.000483	0.000531	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CD36—age related macular degeneration	0.000482	0.000531	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—APOE—age related macular degeneration	0.000476	0.000524	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000474	0.000522	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000474	0.000521	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RHO—age related macular degeneration	0.00047	0.000517	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000469	0.000516	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000463	0.000509	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ELOVL4—age related macular degeneration	0.000462	0.000508	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—C3—age related macular degeneration	0.000461	0.000507	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000453	0.000498	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000446	0.00049	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD36—age related macular degeneration	0.000445	0.00049	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000436	0.00048	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000432	0.000476	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000432	0.000476	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00043	0.000473	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—APOE—age related macular degeneration	0.000429	0.000472	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000428	0.000471	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD36—age related macular degeneration	0.000426	0.000469	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—C3—age related macular degeneration	0.000422	0.000465	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KDR—age related macular degeneration	0.00042	0.000462	CbGpPWpGaD
Gefitinib—EGFR—Disease—CST3—age related macular degeneration	0.00042	0.000462	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—KDR—age related macular degeneration	0.000417	0.000459	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.000414	0.000456	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000413	0.000454	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD36—age related macular degeneration	0.000409	0.00045	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.000408	0.000449	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000405	0.000445	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—C3—age related macular degeneration	0.000403	0.000444	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CRP—age related macular degeneration	0.000402	0.000442	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000395	0.000434	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000392	0.000432	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—C3—age related macular degeneration	0.000387	0.000426	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—TLR4—age related macular degeneration	0.000385	0.000424	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000384	0.000423	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CRP—age related macular degeneration	0.000384	0.000422	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000381	0.000419	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000378	0.000416	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFBR1—age related macular degeneration	0.000377	0.000415	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000372	0.00041	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD36—age related macular degeneration	0.000371	0.000408	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00037	0.000408	CbGpPWpGaD
Gefitinib—EGFR—Immune System—SQSTM1—age related macular degeneration	0.00037	0.000407	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—TLR4—age related macular degeneration	0.000368	0.000405	CbGpPWpGaD
Gefitinib—ERBB3—Disease—APOE—age related macular degeneration	0.000363	0.000399	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCL2—age related macular degeneration	0.00036	0.000397	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—C3—age related macular degeneration	0.000358	0.000394	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000358	0.000394	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—C3—age related macular degeneration	0.000351	0.000387	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00035	0.000385	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000344	0.000378	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000338	0.000372	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CRP—age related macular degeneration	0.000334	0.000368	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000334	0.000368	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—APOE—age related macular degeneration	0.000333	0.000367	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KDR—age related macular degeneration	0.000327	0.00036	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000326	0.000359	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—VEGFA—age related macular degeneration	0.000322	0.000354	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TLR4—age related macular degeneration	0.000321	0.000353	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000309	0.00034	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000307	0.000338	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000305	0.000335	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CETP—age related macular degeneration	0.000298	0.000328	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000285	0.000314	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—C3—age related macular degeneration	0.000283	0.000312	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL2—age related macular degeneration	0.00028	0.000308	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—C3—age related macular degeneration	0.000273	0.0003	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—CD36—age related macular degeneration	0.000272	0.0003	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000272	0.000299	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000264	0.00029	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—APOE—age related macular degeneration	0.000264	0.00029	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KDR—age related macular degeneration	0.000258	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—C3—age related macular degeneration	0.000257	0.000283	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—APOE—age related macular degeneration	0.000254	0.00028	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000252	0.000277	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000249	0.000274	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KDR—age related macular degeneration	0.000249	0.000274	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000248	0.000273	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD36—age related macular degeneration	0.000248	0.000273	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000248	0.000273	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00024	0.000264	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000239	0.000263	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C3—age related macular degeneration	0.000235	0.000259	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—VEGFA—age related macular degeneration	0.000231	0.000255	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—VEGFA—age related macular degeneration	0.00023	0.000253	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—C3—age related macular degeneration	0.000227	0.00025	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—age related macular degeneration	0.000224	0.000246	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000223	0.000245	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—age related macular degeneration	0.000222	0.000244	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000221	0.000243	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000219	0.000241	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—age related macular degeneration	0.000214	0.000236	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—age related macular degeneration	0.000214	0.000235	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000213	0.000235	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—APOE—age related macular degeneration	0.000212	0.000233	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000209	0.00023	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KDR—age related macular degeneration	0.000207	0.000228	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000203	0.000223	CbGpPWpGaD
Gefitinib—EGFR—Disease—APOE—age related macular degeneration	0.000202	0.000222	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000202	0.000222	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—age related macular degeneration	0.000201	0.000221	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000201	0.000221	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000196	0.000216	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LIPC—age related macular degeneration	0.000191	0.00021	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CETP—age related macular degeneration	0.000184	0.000202	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—VEGFA—age related macular degeneration	0.00018	0.000198	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000179	0.000197	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CD36—age related macular degeneration	0.000179	0.000197	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—age related macular degeneration	0.000178	0.000196	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000171	0.000188	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000167	0.000184	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000165	0.000182	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CETP—age related macular degeneration	0.000161	0.000177	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—age related macular degeneration	0.000158	0.000174	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000157	0.000173	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000156	0.000172	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—C3—age related macular degeneration	0.000152	0.000167	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000152	0.000167	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CETP—age related macular degeneration	0.00015	0.000166	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—VEGFA—age related macular degeneration	0.000142	0.000157	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—age related macular degeneration	0.000141	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KDR—age related macular degeneration	0.000139	0.000152	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—VEGFA—age related macular degeneration	0.000137	0.000151	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—VEGFA—age related macular degeneration	0.00013	0.000143	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000128	0.000141	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000121	0.000133	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—age related macular degeneration	0.000119	0.000131	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—VEGFA—age related macular degeneration	0.000114	0.000126	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000113	0.000125	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CD36—age related macular degeneration	0.00011	0.000122	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—age related macular degeneration	0.000107	0.000118	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000103	0.000113	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CETP—age related macular degeneration	9.92e-05	0.000109	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CD36—age related macular degeneration	9.92e-05	0.000109	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—age related macular degeneration	9.74e-05	0.000107	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CD36—age related macular degeneration	9.68e-05	0.000107	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CD36—age related macular degeneration	9.12e-05	0.0001	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CD36—age related macular degeneration	9.04e-05	9.95e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—age related macular degeneration	8.75e-05	9.63e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—age related macular degeneration	8.54e-05	9.4e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—age related macular degeneration	8.05e-05	8.85e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—age related macular degeneration	7.98e-05	8.78e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VEGFA—age related macular degeneration	7.63e-05	8.4e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CD36—age related macular degeneration	5.96e-05	6.56e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—age related macular degeneration	5.26e-05	5.79e-05	CbGpPWpGaD
